日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Access to treatment-guiding biomarkers in the UK: surveys of cancer patients and healthcare professionals

英国癌症患者和医疗保健专业人员对治疗指导生物标志物的获取情况调查

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2535098
Bell, Dany; Bryce, Rachel; Delfino, Rosalia; Godin-Heymann, Nadia; Horne, Jessica; Jäger, Louise; Jones, Michael; Magnell, Niklas; Sharma, Vishali; Shera, David; Ratcliffe, Marianne J; Walls, Kathy; Mughal, Rosie
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

Durvalumab ± Tremelimumab + Platinum-Etoposide治疗广泛期小细胞肺癌（CASPIAN）：PD-L1表达和组织肿瘤突变负荷与疗效的关系

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1689
Paz-Ares, Luis; Garassino, Marina Chiara; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Poltoratskiy, Artem; Trukhin, Dmytro; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Statsenko, Galina; Conev, Nikolay; Bondarenko, Igor; Havel, Libor; Losonczy, György; Xie, Mingchao; Lai, Zhongwu; Godin-Heymann, Nadia; Mann, Helen; Jiang, Haiyi; Shrestha, Yashaswi; Goldman, Jonathan W
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
发表日期：2024
文献求助 收藏

Tumour-suppression function of KLF12 through regulation of anoikis

KLF12 通过调节细胞凋亡发挥肿瘤抑制作用

期刊:Oncogene
影响因子:6.9
doi:10.1038/onc.2015.394
N Godin-Heymann, S Brabetz, M M Murillo, M Saponaro, C R Santos, A Lobley, P East, P Chakravarty, N Matthews, G Kelly, S Jordan, E Castellano, J Downward
信号转导
细胞生物学
肿瘤
其它细胞
Apoptosis
发表日期：2016
文献求助 收藏

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells

ASPP1 和 ASPP2 与活性 RAS 结合，增强 RAS 信号传导，并提高癌细胞中 p53 的活性。

期刊:Cell Death and Differentiation
影响因子:15.4
doi:10.1038/cdd.2013.3
Wang, Y; Godin-Heymann, N; Dan Wang, X; Bergamaschi, D; Llanos, S; Lu, X
肿瘤
肿瘤免疫
信号转导
细胞生物学
RAS
发表日期：2013
文献求助 收藏

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib.

EGF 受体的不可逆抑制剂可以克服对吉非替尼的获得性耐药性

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.0502860102
Kwak Eunice L, Sordella Raffaella, Bell Daphne W, Godin-Heymann Nadia, Okimoto Ross A, Brannigan Brian W, Harris Patricia L, Driscoll David R, Fidias Panos, Lynch Thomas J, Rabindran Sridhar K, McGinnis John P, Wissner Allan, Sharma Sreenath V, Isselbacher Kurt J, Settleman Jeffrey, Haber Daniel A
信号转导
发表日期：2005
文献求助 收藏